RAD9A is a key component of the 9-1-1 checkpoint clamp complex (RAD9A-RAD1-HUS1) that plays critical roles in DNA damage response and repair 1. The protein possesses 3'-5' double-stranded DNA exonuclease activity and functions as a sliding clamp platform recruited to DNA lesions by the RAD17-RFC clamp loader complex 2. RAD9A exhibits cooperative DNA binding through multiple domains, with basic residues (K11, K15, R22, K78, K220, R223) being essential for DNA interaction 2. Mechanistically, RAD9A promotes ATR-CHK1 checkpoint activation by facilitating loading of checkpoint proteins onto chr11 and stabilizes stalled replication forks during replication stress 3. The protein also controls cellular localization of the Claspin adaptor protein, which is vital for Chk1-mediated checkpoint responses 4. Beyond DNA repair, RAD9A functions as a transcriptional regulator, binding p53 consensus sequences to control gene expression, including AGR2 in prostate cancer 5. Disease relevance includes roles in cancer progression, with hypermethylation of RAD9A intron 2 associated with genomic imbalances and tumorigenesis in childhood cancers and leukemia 6. RAD9A overexpression promotes metastatic phenotypes in prostate and colon cancers 57, making it a potential therapeutic target.